PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.64%
Revenue growth at 75-90% of BRZE's 14.73%. Bill Ackman would push for innovation or market expansion to catch up.
12.88%
Gross profit growth at 50-75% of BRZE's 21.06%. Martin Whitman would question if cost structure or brand is lagging.
-3.38%
Negative EBIT growth while BRZE is at 14.01%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-3.38%
Negative operating income growth while BRZE is at 14.01%. Joel Greenblatt would press for urgent turnaround measures.
-3.42%
Negative net income growth while BRZE stands at 28.67%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.20%
Share change of 0.20% while BRZE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.56%
Diluted share change of 1.56% while BRZE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
7.99%
OCF growth under 50% of BRZE's 46.73%. Michael Burry might suspect questionable revenue recognition or rising costs.
5.59%
FCF growth under 50% of BRZE's 39.37%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.64%
R&D growth drastically higher vs. BRZE's 9.86%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
5.93%
SG&A declining or stable vs. BRZE's 13.17%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.